608 related articles for article (PubMed ID: 9244390)
21. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
[TBL] [Abstract][Full Text] [Related]
23. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
Yavelow J; Caggana M; Beck KA
Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds.
Ragg EM; Galbusera V; Scarafoni A; Negri A; Tedeschi G; Consonni A; Sessa F; Duranti M
FEBS J; 2006 Sep; 273(17):4024-39. PubMed ID: 16889634
[TBL] [Abstract][Full Text] [Related]
25. Mast cell chymase. A potent secretagogue for airway gland serous cells.
Sommerhoff CP; Caughey GH; Finkbeiner WE; Lazarus SC; Basbaum CB; Nadel JA
J Immunol; 1989 Apr; 142(7):2450-6. PubMed ID: 2494259
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
He SH; Chen HQ; Zheng J
Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
28. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T
Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982
[TBL] [Abstract][Full Text] [Related]
29. Proteinase inhibition using small Bowman-Birk-type structures.
Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human mast cell tryptase beta: stable expression in Pichia pastoris and purification of fully active enzyme.
Niles AL; Maffitt M; Haak-Frendscho M; Wheeless CJ; Johnson DA
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():125-31. PubMed ID: 9756742
[TBL] [Abstract][Full Text] [Related]
31. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
32. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy.
Beil WJ; Pammer J
Histochem Cell Biol; 2001 Dec; 116(6):483-93. PubMed ID: 11810190
[TBL] [Abstract][Full Text] [Related]
33. Highly efficient inhibition of human chymase by alpha(2)-macroglobulin.
Walter M; Sutton RM; Schechter NM
Arch Biochem Biophys; 1999 Aug; 368(2):276-84. PubMed ID: 10441378
[TBL] [Abstract][Full Text] [Related]
34. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
J Mol Recognit; 1990; 3(5-6):192-6. PubMed ID: 2096886
[TBL] [Abstract][Full Text] [Related]
35. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Safavi F; Rostami A
Exp Mol Pathol; 2012 Dec; 93(3):428-33. PubMed ID: 23022357
[TBL] [Abstract][Full Text] [Related]
36. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.
Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E
Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939
[TBL] [Abstract][Full Text] [Related]
37. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
Weder JK; Hinkers SC
J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
[TBL] [Abstract][Full Text] [Related]
38. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor.
Wan XS; Meyskens FL; Armstrong WB; Taylor TH; Kennedy AR
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):601-8. PubMed ID: 10428197
[TBL] [Abstract][Full Text] [Related]
39. Molecular engineering of a small trypsin inhibitor based on the binding loop of horsegram seed Bowman-Birk inhibitor.
Muricken DG; Gowda LR
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):553-60. PubMed ID: 21171897
[TBL] [Abstract][Full Text] [Related]
40. Formation of active monomers from tetrameric human beta-tryptase.
Fajardo I; Pejler G
Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
